Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Net Income (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Net Income for 16 consecutive years, with -$1.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income fell 209.01% year-over-year to -$1.8 million, compared with a TTM value of -$5.7 million through Sep 2025, down 312.1%, and an annual FY2024 reading of -$554000.0, up 93.68% over the prior year.
  • Net Income was -$1.8 million for Q3 2025 at Rockwell Medical, down from -$1.6 million in the prior quarter.
  • Across five years, Net Income topped out at $1.7 million in Q3 2024 and bottomed at -$8.9 million in Q4 2021.
  • Average Net Income over 5 years is -$3.5 million, with a median of -$2.1 million recorded in 2023.
  • The sharpest move saw Net Income skyrocketed 179.54% in 2024, then plummeted 632.88% in 2025.
  • Year by year, Net Income stood at -$8.9 million in 2021, then soared by 73.61% to -$2.4 million in 2022, then soared by 31.65% to -$1.6 million in 2023, then surged by 51.7% to -$779000.0 in 2024, then crashed by 132.86% to -$1.8 million in 2025.
  • Business Quant data shows Net Income for RMTI at -$1.8 million in Q3 2025, -$1.6 million in Q2 2025, and -$1.6 million in Q1 2025.